Diabetes specialist nurse as main care provider for patients with type 2 diabetes

Netherlands Journal of Medicine

Volumn 67, Issue 7, 2009, Pages 279-284

  Houweling, S T ^a,b   Kleefstra, N ^a,c   Van Hateren, K J J ^c   Kooy, A ^d   Groenier, K H ^b   Ten Vergert, E ^b   Meyboom de Jong, B ^b   Bilo, H J G ^c  

^a LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ISALA HOSPITAL   (Netherlands)

^d Bethesda Hospital   (Netherlands)

Author keywords

Diabetes mellitus type 2; Nurses; Randomised controlled trial

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING EXPERTISE; PATIENT CARE; PATIENT SATISFACTION; PRESCRIPTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NURSE CLINICIANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT CARE MANAGEMENT; PATIENT SATISFACTION; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; SICKNESS IMPACT PROFILE;

EID: 69749116854     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035-2038
2. Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet. 1997;350(Suppl 1):4-9.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projection for 2030. Diabetes Care. 2004;27:2568-2569
4. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes revisited: a prospective population-based study in The Netherlands. Eur J Epidem. 2003;18:793-800.
5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581 (Pubitemid 34517204)
6. Rutten GEHM, Verhoeven S, Heine RJ, et al. NHG-Standaard Diabetes Type 2 (eerste herziening). Huisarts Wet. 1999;42:67-84.
7. Houweling ST, Kleefstra N, Verhoeven S, Ballegooie E van, Bilo HJG. Protocollaire diabeteszorg. Mogelijkheden voor taakdelegatie. Zwolle: Stichting Langerhans, 2004.
8. Richtlijnen en adviezen voor goede diabeteszorg. Leusden: Nederlandse Diabetes Federatie, 2000.
9. El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127-133
10. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483
11. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055-1068 (Pubitemid 28527161)
12. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med. 1994;11:253-261
13. Pouwer F, Snoek FJ. Patients' Evaluation of the Quality of Diabetes Care (PEQD): development and validation of a new instrument. Qual Saf Healthcare. 2002;11:131-136 (Pubitemid 35265275)
14. Dutch Pharmacotherapeutic Compass 2003. Amstelveen: Healthcare Insurance Board (CVZ), 2003.
15. Dutch Diagnostic Compass 2003. Amstelveen: Healthcare Insurance Board (CVZ), 2003.
16. Loveman E, Royle P, Waugh N. Specialist nurses in diabetes mellitus. Cochrane Database Syst Rev. 2003;(2):CD003286.
17. Gary TL, Bone LR, Hill MN, et al. Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev Med. 2003;37:23-32.
18. Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003;26:2281-2287
19. New JP, Mason JM, Freemantle N, et al. Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial. Diabetes Care. 2003;26:2250-2255 (Pubitemid 36993308)
20. Taylor CB, Miller NH, Reilly KR, et al. Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes. Diabetes Care. 2003;26:1058-1063
21. Tobe SW, Pylypchuk G, Wentworth J, et al. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. Can Med Assoc J. 2006;174:1267-1271